Sergey P. Bordovsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sergey P. Bordovsky has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Kseniya V. Shevtsova
Sechenov First Moscow State Medical University (Sechenov University)
8 shared publications - Irina S. Preobrazhenskaya
Sechenov First Moscow State Medical University (Sechenov University)
7 shared publications - Renata T. Murtazina
Sechenov First Moscow State Medical University (Sechenov University)
5 shared publications - Sergey S. Andreev
HSE University
5 shared publications - Anna D. Taranova
Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Pavel M. Krupenin
Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications
Latest Publications
- Open Access
- 24 April 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (2) , 11-18
Transcranial direct current stimulation for Parkinson's disease: a randomized controlled trial (with a sham control)
Transcranial direct current stimulation (tDCS) of the primary motor cortex is being discussed as an adjunct to therapy for Parkinson's disease (PD). The effectiveness of tDCS in PD remains controversial, and there are no data evaluating the efficacy and safety of tDCS in PD in our country. Objective: to evaluate the clinical efficacy of a course of anodal tDCS applied to the primary motor cortex as part of a comprehensive treatment regimen for patients with stage II–III PD according to the Hoehn and Yahr scale, including its effects on motor, cognitive and affective symptoms, as well as the safety and tolerability of the method. Material and methods. A prospective, randomised, controlled trial was conducted involving 46 patients with idiopathic PD (25 men and 21 women; mean age 63.9 ± 11.2 years). The main group (n = 24) received 10 sessions of anodal tDCS to the M1 region (2 mA, 20 min, daily, for 2 weeks), whilst the control group (n = 22) received sham stimulation. The following parameters were assessed before and after the course: motor (Unified Parkinson's Disease Rating Scale – UPDRS; Activity of Daily Living – ADL), cognitive (Montreal Cognitive Assessment – MoCA; Frontal Assessment Battery – FAB; Trail Making Test, Parts A and B – TMT-A, TMT-B; Cue Sensitivity Index of the free recall test with selective cues – CSI) and affective (Starkstein Apathy Scale; Geriatric Depression Scale – GDS; State-Trait Anxiety Inventory – STAI). Results. After covariate adjustment, a statistically significant between-group advantage of active tDCS was found for 8 of 11 assessed outcomes: UPDRS-III (d = -0.49; p < 0.01), ADL (d = -0.59; p = 0.016), apathy (d = -1.07; p < 0.01), depression according to GDS (d = -0.63; p = 0.013), trait anxiety according to STAI (d = -0.67; p = 0.018), state anxiety according to STAI (d = -0.58; p = 0.041), TMT-A (d = -1.00; p = 0.025), and MoCA (d = 0.52; p = 0.024). The most pronounced effects were observed for apathy and TMT-A. No statistically significant between-group differences after adjustment were found for TMT-B (d = -0.39; p = 0.188), FAB (d = -0.25; p = 0.095), and CSI (d = 0.34; p = 0.29). No serious adverse events were recorded throughout the study period. Conclusion. Transcranial direct current stimulation (tDCS) of the primary motor cortex has a high safety profile and may be considered as an adjunctive method in the comprehensive rehabilitation of patients with stage II–III PD, with the most pronounced effects observed in the affective domain and in terms of cognitive processing speed.
- 24 April 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (2) , 11-18
Open AccessTranscranial direct current stimulation for Parkinson's disease: a randomized controlled trial (with a sham control)
Transcranial direct current stimulation (tDCS) of the primary motor cortex is being discussed as an adjunct to therapy for Parkinson's disease (PD). The effectiveness of tDCS in PD remains controversial, and there are no data evaluating the efficacy and safety of tDCS in PD in our country. Objective: to evaluate the clinical efficacy of a course of anodal tDCS applied to the primary motor cortex as part of a comprehensive treatment regimen for patients with stage II–III PD according to the Hoehn and Yahr scale, including its effects on motor, cognitive and affective symptoms, as well as the safety and tolerability of the method. Material and methods. A prospective, randomised, controlled trial was conducted involving 46 patients with idiopathic PD (25 men and 21 women; mean age 63.9 ± 11.2 years). The main group (n = 24) received 10 sessions of anodal tDCS to the M1 region (2 mA, 20 min, daily, for 2 weeks), whilst the control group (n = 22) received sham stimulation. The following parameters were assessed before and after the course: motor (Unified Parkinson's Disease Rating Scale – UPDRS; Activity of Daily Living – ADL), cognitive (Montreal Cognitive Assessment – MoCA; Frontal Assessment Battery – FAB; Trail Making Test, Parts A and B – TMT-A, TMT-B; Cue Sensitivity Index of the free recall test with selective cues – CSI) and affective (Starkstein Apathy Scale; Geriatric Depression Scale – GDS; State-Trait Anxiety Inventory – STAI). Results. After covariate adjustment, a statistically significant between-group advantage of active tDCS was found for 8 of 11 assessed outcomes: UPDRS-III (d = -0.49; p < 0.01), ADL (d = -0.59; p = 0.016), apathy (d = -1.07; p < 0.01), depression according to GDS (d = -0.63; p = 0.013), trait anxiety according to STAI (d = -0.67; p = 0.018), state anxiety according to STAI (d = -0.58; p = 0.041), TMT-A (d = -1.00; p = 0.025), and MoCA (d = 0.52; p = 0.024). The most pronounced effects were observed for apathy and TMT-A. No statistically significant between-group differences after adjustment were found for TMT-B (d = -0.39; p = 0.188), FAB (d = -0.25; p = 0.095), and CSI (d = 0.34; p = 0.29). No serious adverse events were recorded throughout the study period. Conclusion. Transcranial direct current stimulation (tDCS) of the primary motor cortex has a high safety profile and may be considered as an adjunctive method in the comprehensive rehabilitation of patients with stage II–III PD, with the most pronounced effects observed in the affective domain and in terms of cognitive processing speed.
- Open Access
- 10 April 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (2) , 93-101
Neuromodulation for muscle dystonia management: a review
Muscle dystonia represents a group of chronic neurological disorders characterized by pathological muscle contractions, the formation of abnormal postures, and a pronounced reduction in patients’ quality of life. Standard treatment approaches include botulinum toxin therapy and surgical interventions; however, in a subset of patients, therapeutic effects remain insufficient or unstable. Consequently, recent years have seen growing interest in non-invasive neuromodulation techniques, such as transcranial magnetic stimulation and transcranial direct current stimulation, which are considered potential adjunctive therapeutic tools. This review summarizes and critically analyses data from contemporary clinical studies, pilot trials, systematic reviews, and meta-analyses addressing the use of neuromodulation in various forms of muscle dystonia, including focal dystonia and cervical dystonia. Particular attention is paid to stimulation parameters, target regions, and current polarity, including anodal stimulation and cathodal stimulation. Analysis of the available evidence indicates that transcranial magnetic stimulation demonstrates a moderate therapeutic potential in certain forms of dystonia; however, reported outcomes remain heterogeneous. At the same time, most studies investigating transcranial direct current stimulation fail to demonstrate statistically or clinically significant improvement in motor symptoms in focal dystonias, including writer’s cramp and blepharospasm, a finding consistently supported by systematic reviews and meta-analyses. However, the most encouraging results have been observed in cervical dystonia, particularly in studies employing bilateral anodal cerebellar stimulation in combination with motor training. Despite isolated positive findings, the current evidence base does not support the recommendation of transcranial direct current stimulation as a standard treatment for muscle dystonia. Thus, future perspectives of neuromodulation are associated with optimization of stimulation protocols, personalization of therapeutic approaches, and integration of these methods into comprehensive rehabilitation programs aimed at improving functional outcomes and long-term symptom control in patients.
- 10 April 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (2) , 93-101
Open AccessNeuromodulation for muscle dystonia management: a review
Muscle dystonia represents a group of chronic neurological disorders characterized by pathological muscle contractions, the formation of abnormal postures, and a pronounced reduction in patients’ quality of life. Standard treatment approaches include botulinum toxin therapy and surgical interventions; however, in a subset of patients, therapeutic effects remain insufficient or unstable. Consequently, recent years have seen growing interest in non-invasive neuromodulation techniques, such as transcranial magnetic stimulation and transcranial direct current stimulation, which are considered potential adjunctive therapeutic tools. This review summarizes and critically analyses data from contemporary clinical studies, pilot trials, systematic reviews, and meta-analyses addressing the use of neuromodulation in various forms of muscle dystonia, including focal dystonia and cervical dystonia. Particular attention is paid to stimulation parameters, target regions, and current polarity, including anodal stimulation and cathodal stimulation. Analysis of the available evidence indicates that transcranial magnetic stimulation demonstrates a moderate therapeutic potential in certain forms of dystonia; however, reported outcomes remain heterogeneous. At the same time, most studies investigating transcranial direct current stimulation fail to demonstrate statistically or clinically significant improvement in motor symptoms in focal dystonias, including writer’s cramp and blepharospasm, a finding consistently supported by systematic reviews and meta-analyses. However, the most encouraging results have been observed in cervical dystonia, particularly in studies employing bilateral anodal cerebellar stimulation in combination with motor training. Despite isolated positive findings, the current evidence base does not support the recommendation of transcranial direct current stimulation as a standard treatment for muscle dystonia. Thus, future perspectives of neuromodulation are associated with optimization of stimulation protocols, personalization of therapeutic approaches, and integration of these methods into comprehensive rehabilitation programs aimed at improving functional outcomes and long-term symptom control in patients.
- Open Access
- 29 March 2026
- Published by Arterialnaya Gipertenziya in Russian surgical journal
- Vol. 2 (1) , 47-55
A clinical case of non-alcoholic Wernicke's encephalopathy in the late postoperative period
Wernicke’s encephalopathy remains a clinically significant but often underestimated postoperative complication, particularly in the context of the increasing prevalence of non-alcoholic forms of the disease. This report describes a non-alcoholic form of Wernicke’s encephalopathy in an 84-year-old female patient who underwent surgical treatment for transverse colon cancer with right hemicolectomy, ileostomy creation, and a prolonged course of parenteral nutrition. In the postoperative period, the patient gradually developed oculomotor dysfunction, cerebellar ataxia, and impaired consciousness. The diagnosis was established based on the clinical presentation and findings on magnetic resonance imaging. Concomitant metabolic disturbances, including hypokalemia and metabolic alkalosis, in the absence of marked laboratory-confirmed thiamine deficiency, complicated early diagnosis. Administration of high-dose thiamine therapy led to rapid clinical improvement. This case highlights the need for clinical vigilance regarding non-alcoholic forms of Wernicke’s encephalopathy in surgical patients at risk of malabsorption and nutritional deficiency, as well as the importance of timely prevention and raising awareness of the pathogenesis and clinical features of the disease in modern medical practice.
- 29 March 2026
- Published by Arterialnaya Gipertenziya in Russian surgical journal
- Vol. 2 (1) , 47-55
Open AccessA clinical case of non-alcoholic Wernicke's encephalopathy in the late postoperative period
Wernicke’s encephalopathy remains a clinically significant but often underestimated postoperative complication, particularly in the context of the increasing prevalence of non-alcoholic forms of the disease. This report describes a non-alcoholic form of Wernicke’s encephalopathy in an 84-year-old female patient who underwent surgical treatment for transverse colon cancer with right hemicolectomy, ileostomy creation, and a prolonged course of parenteral nutrition. In the postoperative period, the patient gradually developed oculomotor dysfunction, cerebellar ataxia, and impaired consciousness. The diagnosis was established based on the clinical presentation and findings on magnetic resonance imaging. Concomitant metabolic disturbances, including hypokalemia and metabolic alkalosis, in the absence of marked laboratory-confirmed thiamine deficiency, complicated early diagnosis. Administration of high-dose thiamine therapy led to rapid clinical improvement. This case highlights the need for clinical vigilance regarding non-alcoholic forms of Wernicke’s encephalopathy in surgical patients at risk of malabsorption and nutritional deficiency, as well as the importance of timely prevention and raising awareness of the pathogenesis and clinical features of the disease in modern medical practice.
- Open Access
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 144-151
Transcranial direct current stimulation in early-onset Parkinson’s disease
Introduction. Transcranial direct current stimulation (tDCS) is a novel adjunctive method for treating Parkinson’s disease (PD) symptoms. However, its efficacy and safety in patients with early-onset PD remain insufficiently studied. Aim. To evaluate the effect of a course of anodal tDCS on motor, cognitive, and affective functions in patients with earlyonset PD. Materials and methods. In this prospective study, five patients (aged 37–49 years) with clinically confirmed PD (mean disease duration 3.3 ± 4.7 years) were included. All patients received standard antiparkinsonian therapy and a course of 10 anodal tDCS sessions (2 mA, 20 min each, daily for 2 weeks). Motor function (UPDRS-III), cognitive status (MoCA, FAB, TMT-A/B), and affective measures (Beck Depression Inventory, State-Trait Anxiety Inventory, Apathy Scale) were assessed before and after the course. Results. After completing the tDCS course, the mean UPDRS-III score significantly decreased by 19–20 % (p < 0.05), indicating improved motor function. Cognitive (MoCA, FAB, TMT) and affective (BDI, STAI, Apathy Scale) scores improved slightly but not significantly. No adverse events or dropouts occurred, the procedures were well tolerated by all participants. Conclusion. These results suggest potential efficacy and a high safety profile of anodal tDCS as an adjunctive therapy in earlyonset PD. As a non-invasive, easily administered technique, tDCS is a promising tool for neuromodulation and rehabilitation in PD. However, further larger randomized trials with long-term follow-up are warranted to confirm these findings.
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 144-151
Open AccessTranscranial direct current stimulation in early-onset Parkinson’s disease
Introduction. Transcranial direct current stimulation (tDCS) is a novel adjunctive method for treating Parkinson’s disease (PD) symptoms. However, its efficacy and safety in patients with early-onset PD remain insufficiently studied. Aim. To evaluate the effect of a course of anodal tDCS on motor, cognitive, and affective functions in patients with earlyonset PD. Materials and methods. In this prospective study, five patients (aged 37–49 years) with clinically confirmed PD (mean disease duration 3.3 ± 4.7 years) were included. All patients received standard antiparkinsonian therapy and a course of 10 anodal tDCS sessions (2 mA, 20 min each, daily for 2 weeks). Motor function (UPDRS-III), cognitive status (MoCA, FAB, TMT-A/B), and affective measures (Beck Depression Inventory, State-Trait Anxiety Inventory, Apathy Scale) were assessed before and after the course. Results. After completing the tDCS course, the mean UPDRS-III score significantly decreased by 19–20 % (p < 0.05), indicating improved motor function. Cognitive (MoCA, FAB, TMT) and affective (BDI, STAI, Apathy Scale) scores improved slightly but not significantly. No adverse events or dropouts occurred, the procedures were well tolerated by all participants. Conclusion. These results suggest potential efficacy and a high safety profile of anodal tDCS as an adjunctive therapy in earlyonset PD. As a non-invasive, easily administered technique, tDCS is a promising tool for neuromodulation and rehabilitation in PD. However, further larger randomized trials with long-term follow-up are warranted to confirm these findings.
- Open Access
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 47-54
Non-pharmacological approaches to migraine management
Migraine is a prevalent and socially significant neurological disorder that requires a comprehensive approach to both treatment and prevention. Non-pharmacological methods of migraine prevention are discussed. Particular attention is given to behavioral and lifestyle interventions such as trigger management, sleep and dietary hygiene, regular aerobic exercise, weight control, and cognitive-behavioral therapy (CBT). These approaches form the basis of non-pharmacological tactics in routine practice. In addition, methods targeting the neurobiological mechanisms of migraine are reviewed, including acupuncture, nutraceuticals (magnesium, riboflavin, coenzyme Q10, vitamin D, etc.), dietary interventions (ketogenic and DASH diets), and non-invasive neuromodulation (high-frequency transcranial magnetic stimulation, transcranial direct current stimulation, trigeminal and vagus nerve stimulation, and remote electrical neuromodulation). Non-pharmacological prevention significantly broadens the therapeutic arsenal for migraine. However, key challenges remain in the standardization of neuromodulation protocols, harmonization of outcome measures and follow-up durations, and validation of nutraceutical efficacy. In clinical practice, the most consistent preventive outcomes are achieved through an individualized approach emphasizing lifestyle modification, patient education, and CBT. A comprehensive approach is considered a promising strategy for managing patients with migraine. The synergistic effect of combining behavioral, physical, and instrumental techniques exceeds the results of their isolated use, making a comprehensive multimodal approach the most promising and reasonable tactic for achieving sustainable control over migraine, minimizing disability, and improving patients’ quality of life in the long term.
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 47-54
Open AccessNon-pharmacological approaches to migraine management
Migraine is a prevalent and socially significant neurological disorder that requires a comprehensive approach to both treatment and prevention. Non-pharmacological methods of migraine prevention are discussed. Particular attention is given to behavioral and lifestyle interventions such as trigger management, sleep and dietary hygiene, regular aerobic exercise, weight control, and cognitive-behavioral therapy (CBT). These approaches form the basis of non-pharmacological tactics in routine practice. In addition, methods targeting the neurobiological mechanisms of migraine are reviewed, including acupuncture, nutraceuticals (magnesium, riboflavin, coenzyme Q10, vitamin D, etc.), dietary interventions (ketogenic and DASH diets), and non-invasive neuromodulation (high-frequency transcranial magnetic stimulation, transcranial direct current stimulation, trigeminal and vagus nerve stimulation, and remote electrical neuromodulation). Non-pharmacological prevention significantly broadens the therapeutic arsenal for migraine. However, key challenges remain in the standardization of neuromodulation protocols, harmonization of outcome measures and follow-up durations, and validation of nutraceutical efficacy. In clinical practice, the most consistent preventive outcomes are achieved through an individualized approach emphasizing lifestyle modification, patient education, and CBT. A comprehensive approach is considered a promising strategy for managing patients with migraine. The synergistic effect of combining behavioral, physical, and instrumental techniques exceeds the results of their isolated use, making a comprehensive multimodal approach the most promising and reasonable tactic for achieving sustainable control over migraine, minimizing disability, and improving patients’ quality of life in the long term.
- Open Access
- 12 December 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (11) , 659-664
Transcranial direct current stimulation in Parkinson’s disease management
Background. Transcranial direct current stimulation (tDCS) is discussed as a promising noninvasive neuromodulation method for alleviating symptoms of Parkinson’s disease (PD). However, evidence on the efficacy of tDCS in PD remains limited in our country. Aim. To evaluate the effect of a course of noninvasive anodal tDCS on the motor symptoms, cognitive function, and emotional state of patients with PD. Materials and methods. Twenty-nine patients with PD (Hoehn and Yahr stages I–III), aged 45–80 years, received anodal tDCS over the dorsolateral prefrontal cortex (DLPFC) at 2 mA for 20 minutes, once daily, 5 days per week for 2 weeks (10 sessions total). Pre- and post-treatment assessments included motor function (Unified Parkinson’s Disease Rating Scale, Part III [UPDRS-III]), cognition (Montreal Cognitive Assessment [MoCA], Frontal Assessment Battery [FAB], Trail Making Test Parts A and B [TMT-A/B]), and affective measures (Apathy Scale; State-Trait Anxiety Inventory-trait and state; Geriatric Depression Scale [GDS]). Results. After the tDCS course, there was a statistically significant improvement in cognitive measures (higher MoCA scores and shorter TMT-A/B completion times), a reduction in motor deficit (lower UPDRS-III scores), and a decrease in apathy and trait anxiety (p0,05). No significant changes were observed on the FAB, state anxiety, or GDS. No adverse events were reported during tDCS in PD. Conclusion. A course of tDCS appears safe and may improve cognitive, affective (apathy, anxiety), and motor symptoms in PD. Randomized, sham-controlled trials are warranted to confirm efficacy and to determine optimal stimulation parameters.
- 12 December 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (11) , 659-664
Open AccessTranscranial direct current stimulation in Parkinson’s disease management
Background. Transcranial direct current stimulation (tDCS) is discussed as a promising noninvasive neuromodulation method for alleviating symptoms of Parkinson’s disease (PD). However, evidence on the efficacy of tDCS in PD remains limited in our country. Aim. To evaluate the effect of a course of noninvasive anodal tDCS on the motor symptoms, cognitive function, and emotional state of patients with PD. Materials and methods. Twenty-nine patients with PD (Hoehn and Yahr stages I–III), aged 45–80 years, received anodal tDCS over the dorsolateral prefrontal cortex (DLPFC) at 2 mA for 20 minutes, once daily, 5 days per week for 2 weeks (10 sessions total). Pre- and post-treatment assessments included motor function (Unified Parkinson’s Disease Rating Scale, Part III [UPDRS-III]), cognition (Montreal Cognitive Assessment [MoCA], Frontal Assessment Battery [FAB], Trail Making Test Parts A and B [TMT-A/B]), and affective measures (Apathy Scale; State-Trait Anxiety Inventory-trait and state; Geriatric Depression Scale [GDS]). Results. After the tDCS course, there was a statistically significant improvement in cognitive measures (higher MoCA scores and shorter TMT-A/B completion times), a reduction in motor deficit (lower UPDRS-III scores), and a decrease in apathy and trait anxiety (p0,05). No significant changes were observed on the FAB, state anxiety, or GDS. No adverse events were reported during tDCS in PD. Conclusion. A course of tDCS appears safe and may improve cognitive, affective (apathy, anxiety), and motor symptoms in PD. Randomized, sham-controlled trials are warranted to confirm efficacy and to determine optimal stimulation parameters.
- Open Access
- 12 November 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (5) , 97-104
Breast Milk and Risk Assessment of Vertical Transmission of Viruses During Breastfeeding
Relevance. Breast milk is a vital source of nutrition and immune protection for newborns. The potential risk of transmitting various viral infections from the mother to the newborn during breastfeeding makes the issue of viral contamination in breast milk a relevant area of research. Aim. To present data on viruses found in breast milk and the associated health risks based on foreign scientific publications. Conclusion. Despite the possibility of certain viruses being present in breast milk, existing scientific evidence confirms that, in most cases, the benefits of breastfeeding significantly outweigh the potential risks, especially when preventive measures are taken. Therefore, a comprehensive approach to assessing the risks and benefits of breastfeeding is essential for ensuring the health of both the mother and the child.
- 12 November 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (5) , 97-104
Open AccessBreast Milk and Risk Assessment of Vertical Transmission of Viruses During Breastfeeding
Relevance. Breast milk is a vital source of nutrition and immune protection for newborns. The potential risk of transmitting various viral infections from the mother to the newborn during breastfeeding makes the issue of viral contamination in breast milk a relevant area of research. Aim. To present data on viruses found in breast milk and the associated health risks based on foreign scientific publications. Conclusion. Despite the possibility of certain viruses being present in breast milk, existing scientific evidence confirms that, in most cases, the benefits of breastfeeding significantly outweigh the potential risks, especially when preventive measures are taken. Therefore, a comprehensive approach to assessing the risks and benefits of breastfeeding is essential for ensuring the health of both the mother and the child.
- Open Access
- 8 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 82-91
Transcranial direct current stimulation in Parkinson’s disease
Parkinson’s disease is one of the most common neurodegenerative pathologies manifested by progressive motor and cognitiveaffective disorders. In the context of global population aging, the prevalence of pathology continues to grow steadily, which creates a significant medical and social burden on health care systems and determines the relevance of the search for new therapeutic approaches. As an additional method of Parkinson’s disease treatment transcranial direct current stimulation (tDCS) is used to reduce motor and non-motor manifestations. Randomized controlled trials, meta-analyses, and systematic reviews have been conducted to evaluate the efficacy of tDCS in Parkinson’s disease. Clinical studies demonstrate the significant potential of tDCS for the correction of motor impairments, with a focus on symptoms of hypokinesia, postural instability, gait disturbances, and cognitive impairment, with the most pronounced positive changes in executive function and working memory. Additionally, there is a positive effect on the affective sphere, manifested in a reliable reduction of depressive symptomatology according to standardized assessment scales. In addition, there is strong evidence of a normalizing effect on sleep architecture, including improvements in sleep duration and quality, which is of particular importance in patients with comorbid sleep disorders. Overall, tDCS represents a promising direction in the complex therapy of Parkinson’s disease, demonstrating a good safety profile and a wide range of therapeutic effects. The greatest clinical efficacy is achieved when optimized stimulation protocols are used in combination with other rehabilitation methods. Future research should focus on developing personalized approaches and more thorough investigation of long-term effects.
- 8 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 82-91
Open AccessTranscranial direct current stimulation in Parkinson’s disease
Parkinson’s disease is one of the most common neurodegenerative pathologies manifested by progressive motor and cognitiveaffective disorders. In the context of global population aging, the prevalence of pathology continues to grow steadily, which creates a significant medical and social burden on health care systems and determines the relevance of the search for new therapeutic approaches. As an additional method of Parkinson’s disease treatment transcranial direct current stimulation (tDCS) is used to reduce motor and non-motor manifestations. Randomized controlled trials, meta-analyses, and systematic reviews have been conducted to evaluate the efficacy of tDCS in Parkinson’s disease. Clinical studies demonstrate the significant potential of tDCS for the correction of motor impairments, with a focus on symptoms of hypokinesia, postural instability, gait disturbances, and cognitive impairment, with the most pronounced positive changes in executive function and working memory. Additionally, there is a positive effect on the affective sphere, manifested in a reliable reduction of depressive symptomatology according to standardized assessment scales. In addition, there is strong evidence of a normalizing effect on sleep architecture, including improvements in sleep duration and quality, which is of particular importance in patients with comorbid sleep disorders. Overall, tDCS represents a promising direction in the complex therapy of Parkinson’s disease, demonstrating a good safety profile and a wide range of therapeutic effects. The greatest clinical efficacy is achieved when optimized stimulation protocols are used in combination with other rehabilitation methods. Future research should focus on developing personalized approaches and more thorough investigation of long-term effects.
- Open Access
- 1 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 51-59
Transcranial direct current stimulation for migrane
Migraine is one of the most common primary headache disorders. Nowadays, there is an increase in the prevalence of migraine. It causes a significant reduction in the Quality of Life of those affected. There are two major approaches to treating migraines: attack management and prevention. The concept of primary prophylactic therapy of migraine has developed rapidly. In addition to standard medication, there are increasing data indicating the usefulness and feasibility of non-drug treatments, such as TES (transcranial electrical stimulation). Both cathodal and anodal stimulation have been shown to be effective in migraine treatment: after a course of TES, the number of days per month with headache decreased, the duration and intensity of migraine attacks decreased, and some studies reported a reduction in the number of medications used. O1/O2 (1–2 mA) for cathodal stimulation and F3/F4 (1–2 mA) for anodal stimulation were the most frequently stimulated cortical areas. The average duration of each session was 20 minutes. The length of TES sessions varied from study to study. TES has shown efficacy and safety in treating various forms of migraine. Using this non-invasive method to prevent attacks may be one of the directions for personalizing migraine treatment.
- 1 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 51-59
Open AccessTranscranial direct current stimulation for migrane
Migraine is one of the most common primary headache disorders. Nowadays, there is an increase in the prevalence of migraine. It causes a significant reduction in the Quality of Life of those affected. There are two major approaches to treating migraines: attack management and prevention. The concept of primary prophylactic therapy of migraine has developed rapidly. In addition to standard medication, there are increasing data indicating the usefulness and feasibility of non-drug treatments, such as TES (transcranial electrical stimulation). Both cathodal and anodal stimulation have been shown to be effective in migraine treatment: after a course of TES, the number of days per month with headache decreased, the duration and intensity of migraine attacks decreased, and some studies reported a reduction in the number of medications used. O1/O2 (1–2 mA) for cathodal stimulation and F3/F4 (1–2 mA) for anodal stimulation were the most frequently stimulated cortical areas. The average duration of each session was 20 minutes. The length of TES sessions varied from study to study. TES has shown efficacy and safety in treating various forms of migraine. Using this non-invasive method to prevent attacks may be one of the directions for personalizing migraine treatment.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Medical Education and Professional Development
- Vol. 15 (3)
INDIVIDUAL EDUCATIONAL TRAJECTORY AS A TOOL FOR DEVELOPING STUDENTS’ ENTREPRENEURIAL COMPETENCES IN MEDICAL UNIVERSITY
ИНДИВИДУАЛЬНАЯ ОБРАЗОВАТЕЛЬНАЯ ТРАЕКТОРИЯ КАК ИНСТРУМЕНТ ФОРМИРОВАНИЯ ПРЕДПРИНИМАТЕЛЬСКИХ КОМПЕТЕНЦИЙ У СТУДЕНТОВ МЕДИЦИНСКОГО ВУЗА
- 1 January 2024
- Published by Geotar-Media Publishing Group in Medical Education and Professional Development
- Vol. 15 (3)
Open AccessINDIVIDUAL EDUCATIONAL TRAJECTORY AS A TOOL FOR DEVELOPING STUDENTS’ ENTREPRENEURIAL COMPETENCES IN MEDICAL UNIVERSITY
ИНДИВИДУАЛЬНАЯ ОБРАЗОВАТЕЛЬНАЯ ТРАЕКТОРИЯ КАК ИНСТРУМЕНТ ФОРМИРОВАНИЯ ПРЕДПРИНИМАТЕЛЬСКИХ КОМПЕТЕНЦИЙ У СТУДЕНТОВ МЕДИЦИНСКОГО ВУЗА